Amiodarone-Induced Hyponatremia in An Elderly Patient: A Rare Case Report.
adverse drug reaction
amiodarone
hyponatremia
syndrome of inappropriate antidiuretic hormone secretion
Journal
Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
medline:
17
5
2023
pubmed:
31
10
2021
entrez:
30
10
2021
Statut:
ppublish
Résumé
Amiodarone is an antiarrhythmic drug belonging to Vaughan-Williams Class III with additional Class IV effects, which is known to cause many adverse drug reactions (ADRs) necessitating close monitoring. In about 20% of patients, their therapy is discontinued due to adverse effects such as hepatic impairment, thyroid dysfunction, and several pulmonary complications. Although dyselectrolytemia is a common adverse reaction reported with many cardiac medications, the incidence of hyponatremia associated with amiodarone intake is not reported widely in the literature. We are reporting a case of a 73-year-old female patient, with hypertension and ischemic heart disease (IHD) receiving oral amiodarone, presenting with severe hyponatremia, requiring recurrent hospitalization. Amiodarone was found to be responsible after evaluating for the possible causes of hyponatremia. As the incidence of amiodarone-associated hyponatremia is unknown, and not many cases are reported, this case report serves to sensitize the clinician to consider amiodarone-induced hyponatremia as one of the differential diagnoses in cases of unexplained hyponatremia.
Identifiants
pubmed: 34715751
doi: 10.1177/08971900211054199
doi:
Substances chimiques
Amiodarone
N3RQ532IUT
Anti-Arrhythmia Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM